Co-Authors
This is a "connection" page, showing publications co-authored by ISSAM I RAAD and VICTOR EDUARDO MULANOVICH.
Connection Strength
1.764
-
International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship. medRxiv. 2022 Aug 26.
Score: 0.223
-
A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies. Open Forum Infect Dis. 2022 Jun; 9(6):ofac079.
Score: 0.215
-
Impact of Checkpoint Inhibitor Immunotherapy, Primarily Pembrolizumab, on Infection Risk in Patients With Advanced Lung Cancer: A Comparative Retrospective Cohort Study. Clin Infect Dis. 2021 11 02; 73(9):e2697-e2704.
Score: 0.211
-
The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer score. Cancer Med. 2021 12; 10(23):8475-8482.
Score: 0.211
-
Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol. Antimicrob Agents Chemother. 2016 06; 60(6):3426-32.
Score: 0.145
-
Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer. Antimicrob Agents Chemother. 2016 01; 60(1):239-44.
Score: 0.139
-
Cluster and sporadic cases of herbaspirillum species infections in patients with cancer. Clin Infect Dis. 2015 Jan 01; 60(1):48-54.
Score: 0.128
-
Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents. 2010 Aug; 36(2):182-6.
Score: 0.095
-
Random plasma concentrations of voriconazole decline over time. J Infect. 2007 Nov; 55(5):e129-30.
Score: 0.079
-
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife. 2023 01 30; 12.
Score: 0.057
-
Immune reconstitution and severity of COVID-19 among hematopoietic cell transplant recipients. Transpl Infect Dis. 2021 Aug; 23(4):e13606.
Score: 0.051
-
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts. Mediterr J Hematol Infect Dis. 2020; 12(1):e2020044.
Score: 0.048
-
Migratory Pulmonary Infiltrates in a Patient With COVID-19 Infection and the Role of Corticosteroids. Mayo Clin Proc. 2020 09; 95(9):2038-2040.
Score: 0.048
-
Clinical Outcomes Associated With Linezolid Resistance in Leukemia Patients With Linezolid-Resistant Staphylococcus epidermidis Bacteremia. Open Forum Infect Dis. 2018 Jul; 5(7):ofy167.
Score: 0.042
-
Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist. 2012; 17(10):1329-36.
Score: 0.028
-
Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis. 2010 Feb 01; 50(3):374-80.
Score: 0.023
-
Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution. Medicine (Baltimore). 2009 Jul; 88(4):211-220.
Score: 0.022